Blood glucose monitoring is still a multiple daily event for most of us. Here are some tools from some of the bigger players Abbott and Roche, as well as newcomer Trividia Health. There’s also news from Ascensia about a study of Type read more »

Diabetes healthcare is being boosted by greater access to and understanding of what these little bits of wearable wellness can do for users. When we published a feature, A Sensor Adventure, in the summer of 2017, there really weren’t that many about, they read more »

The Eversense system continually measures interstitial fluid glucose levels in adults with diabetes for the operating life of the sensor, which is 180 days (six months). Although the CGM is implanted the user wears a reader on the skin, which delivers glucose trend read more »

‘Violin man’ and Type 2 diabetic, David Andrews. David Andrews took early retirement from teaching 10 years ago, then rather unexpectedly ended up with a second career that still keeps him busy, restoring violins. His website can be found at www.violinman.com, a cottage read more »

Could OurPath help change your lifestyle, for good? OurPath provides in-your-pocket access to the latest nutrition, behaviour science, your own health coach plus support from others on the OurPath journey. For many people, weight management is a tough, very personal and frustrating experience. read more »

Roche has received CE Mark for its Accu-Chek Solo micropump system. The company will start a pilot commercialisation phase for this new insulin delivery system in Austria, Poland, Switzerland and the UK in the coming weeks and is currently conducting a clinical read more »

Moby, a Medical Detection Dog Moby is the dog sponsored by Accu-Chek Mobile to be trained by Medical Detection Dogs in order to become a partner to a person with diabetes who has extra needs, such as having no hypo awareness. Claire Pesterfield who read more »

Roche’s Accu-Chek brand is bringing Senseonic’s Eversense CGM to the UK and other countries in Europe shortly, having gained CE clearance last week (14 September 2017). A recent survey of 17,317 Type 1 diabetes (T1D) individuals in the American-based T1D Exchange registry reported read more »

The Eversense Continuous Glucose Monitoring (CGM) System from Senseonics has been granted an EU CE mark approval. An implantable and long-term glucose sensor, the Eversense CGM eliminates the need for weekly sensor insertion. Senseonics Holdings, Inc. has also signed an exclusive distribution agreement read more »